<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK154138" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK154138/" /><meta name="ncbi_pagename" content="Urofacial Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Urofacial Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Urofacial Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/06/07" /><meta name="citation_author" content="William G Newman" /><meta name="citation_author" content="Adrian S Woolf" /><meta name="citation_pmid" content="23967498" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK154138/" /><meta name="citation_keywords" content="Ochoa Syndrome" /><meta name="citation_keywords" content="Ochoa Syndrome" /><meta name="citation_keywords" content="Inactive heparanase-2" /><meta name="citation_keywords" content="Leucine-rich repeats and immunoglobulin-like domains protein 2" /><meta name="citation_keywords" content="HPSE2" /><meta name="citation_keywords" content="LRIG2" /><meta name="citation_keywords" content="Urofacial Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Urofacial Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="William G Newman" /><meta name="DC.Contributor" content="Adrian S Woolf" /><meta name="DC.Date" content="2018/06/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK154138/" /><meta name="description" content="Urofacial syndrome (UFS) is characterized by prenatal or infantile onset of urinary bladder voiding dysfunction, abnormal facial movement with expression (resulting from abnormal co-contraction of the corners of the mouth and eyes), and often bowel dysfunction (constipation and/or encopresis). Bladder voiding dysfunction increases the risk for urinary incontinence, megacystis, vesicoureteric reflux, hydroureteronephrosis, urosepsis, and progressive renal impairment. In rare instances, an individual who has (a) a molecularly confirmed diagnosis and/or (b) an affected relative meeting clinical diagnostic criteria manifests only the characteristic facial features or only the urinary bladder voiding dysfunction (not both). Nocturnal lagophthalmos (incomplete closing of the eyes during sleep) appears to be a common and significant finding." /><meta name="og:title" content="Urofacial Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Urofacial syndrome (UFS) is characterized by prenatal or infantile onset of urinary bladder voiding dysfunction, abnormal facial movement with expression (resulting from abnormal co-contraction of the corners of the mouth and eyes), and often bowel dysfunction (constipation and/or encopresis). Bladder voiding dysfunction increases the risk for urinary incontinence, megacystis, vesicoureteric reflux, hydroureteronephrosis, urosepsis, and progressive renal impairment. In rare instances, an individual who has (a) a molecularly confirmed diagnosis and/or (b) an affected relative meeting clinical diagnostic criteria manifests only the characteristic facial features or only the urinary bladder voiding dysfunction (not both). Nocturnal lagophthalmos (incomplete closing of the eyes during sleep) appears to be a common and significant finding." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK154138/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/urofacial/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK154138/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88701FDFC875E1000000000341015F.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK154138_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK154138_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ucd-overview/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/usher1/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK154138_"><span class="title" itemprop="name">Urofacial Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Ochoa Syndrome</div><p class="contrib-group"><span itemprop="author">William G Newman</span>, MD, PhD and <span itemprop="author">Adrian S Woolf</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK154138_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK154138_ai__"><div class="contrib half_rhythm"><span itemprop="author">William G Newman</span>, MD, PhD<div class="affiliation small">Manchester Centre for Genomic Medicine, Evolution and Genomic Sciences<br />University of Manchester and Manchester University NHS Foundation Trust<br />Manchester, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.retsehcnam@namwen.mailliw" class="oemail">ku.ca.retsehcnam@namwen.mailliw</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Adrian S Woolf</span>, MD<div class="affiliation small">Centre for Paediatrics and Child Health<br />University of Manchester and Manchester University NHS Foundation Trust<br />Manchester, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.retsehcnam@floow.nairda" class="oemail">ku.ca.retsehcnam@floow.nairda</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">August 22, 2013</span>; Last Update: <span itemprop="dateModified">June 7, 2018</span>.</p><p><em>Estimated reading time: 17 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="urofacial.Summary" itemprop="description"><h2 id="_urofacial_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Urofacial syndrome (UFS) is characterized by prenatal or infantile onset of urinary bladder voiding dysfunction, abnormal facial movement with expression (resulting from abnormal co-contraction of the corners of the mouth and eyes), and often bowel dysfunction (constipation and/or encopresis). Bladder voiding dysfunction increases the risk for urinary incontinence, megacystis, vesicoureteric reflux, hydroureteronephrosis, urosepsis, and progressive renal impairment. In rare instances, an individual who has (a) a molecularly confirmed diagnosis and/or (b) an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> relative meeting clinical diagnostic criteria manifests only the characteristic facial features or only the urinary bladder voiding dysfunction (not both). Nocturnal lagophthalmos (incomplete closing of the eyes during sleep) appears to be a common and significant finding.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of UFS is based on investigations of the urinary tract that reveal characteristic urinary tract abnormalities and physical examination that reveals characteristic facial movement with expression. UFS is a heterogeneous condition resulting from <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in either <i>HPSE2</i> or <i>LRIG2</i>. In some instances no pathogenic change has been identified. Note that the majority of individuals with UFS reported to date have not had molecular confirmation of their diagnosis.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Rapid and complete treatment of urinary tract infections and routine treatment of urosepsis. For urinary incontinence and bladder dysfunction: use of anticholinergic and &#x003b1;<sub>1</sub>-adrenergic blockers; intermittent catheterization or vesicostomy; surgical management of hydroureteronephrosis and bladder augmentation should be considered. Management of chronic kidney disease and end-stage renal disease relies on the standard optimal options.</p><p><i>Surveillance:</i> Monitor for evidence of urinary tract features including vesicoureteric reflux and hydroureteronephrosis. Renal function should be monitored at intervals determined by urinary tract features at presentation and their subsequent progression.</p><p><i>Agents/circumstances to avoid:</i> Nephrotoxic substances.</p><p><i>Evaluation of relatives at risk:</i> It is appropriate to examine sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual as soon as possible after birth to determine if facial and/or urinary tract manifestations of UFS are present to allow prompt evaluation of the urinary tract and renal function and prompt initiation of necessary treatment.</p><p><i>Pregnancy management:</i> Although no guidelines for prenatal management of UFS exist, it seems appropriate to perform ultrasound examination of pregnancies at risk to determine if urinary tract involvement of UFS is present, as this may influence the timing and/or location of delivery (e.g., in a tertiary medical center that could manage renal/urinary complications immediately after birth).</p></div><div><h4 class="inline">Genetic counseling.</h4><p>UFS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives, prenatal testing of pregnancies at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible if the pathogenic variants in the family are known.</p></div></div><div id="urofacial.Diagnosis"><h2 id="_urofacial_Diagnosis_">Diagnosis</h2><p>No formal diagnostic criteria for urofacial syndrome (UFS) have been published.</p><div id="urofacial.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Urofacial syndrome (UFS) <b>should be suspected</b> in individuals with the following clinical findings.</p><p><b>Classic clinical findings</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Urinary bladder dysfunction</b> (also termed non-neurogenic neurogenic voiding dysfunction, occult or subclinical neuropathic bladder) with detrusor overactivity and detrusor sphincter dyssynergia [<a class="bk_pop" href="#urofacial.REF.feldman.2006.139">Feldman &#x00026; Bauer 2006</a>]. Affected individuals are at risk for urinary incontinence, urosepsis, and progressive renal impairment [<a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>, <a class="bk_pop" href="#urofacial.REF.aydogdu.2010.431">Aydogdu et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2013.259">Stuart et al 2013</a>]. Urinary tract features have been present in nearly all reported individuals [<a class="bk_pop" href="#urofacial.REF.aydogdu.2010.431">Aydogdu et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2013.259">Stuart et al 2013</a>].</div><div class="half_rhythm">Characteristic urinary tract abnormalities:</div><ul><li class="half_rhythm"><div>Postnatal imaging of the bladder typically shows muscular thickening and trabeculation, but may also be normal [<a class="bk_pop" href="#urofacial.REF.ochoa.1992.580">Ochoa 1992</a>, <a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>, <a class="bk_pop" href="#urofacial.REF.derbent.2009.589">Derbent et al 2009</a>, <a class="bk_pop" href="#urofacial.REF.aydogdu.2010.431">Aydogdu et al 2010</a>].</div></li><li class="half_rhythm"><div>Hydroureteronephrosis is common [<a class="bk_pop" href="#urofacial.REF.ochoa.1992.580">Ochoa 1992</a>, <a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>].</div></li><li class="half_rhythm"><div>Micturating cystourethrogram may reveal vesicoureteric reflux [<a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>]; intra-urethral anatomic lesions are not observed.</div></li></ul><div class="half_rhythm">Cystoscopy, if performed, reveals no urethral lesions.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A characteristic abnormality of facial movement with expression,</b> resulting from abnormal co-contraction of the corners of the mouth and eyes, which is most obvious during smiling or laughing and often described as a "grimace" [<a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>, <a class="bk_pop" href="#urofacial.REF.aydogdu.2010.431">Aydogdu et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.ganesan.2011.507">Ganesan &#x00026; Thomas 2011</a>]. Typical facial expressions have been present in all but one individual (who was diagnosed due to classic features in a relative) [<a class="bk_pop" href="#urofacial.REF.aydogdu.2010.431">Aydogdu et al 2010</a>].</div></li></ul><p><b>Other clinical findings</b></p><ul><li class="half_rhythm"><div><b>Bowel dysfunction,</b> including constipation, reported in about 66% and encopresis in 33% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>]</div></li><li class="half_rhythm"><div><b>Nocturnal lagophthalmos</b> (incomplete closing of the eyelids during sleep)</div></li></ul></div><div id="urofacial.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of UFS <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by either of the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">The presence of the two main clinical features involving the urinary bladder and face described in <a href="#urofacial.Suggestive_Findings">Suggestive Findings</a> [<a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>]</div></li><li class="half_rhythm"><div class="half_rhythm">Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in either <i>HPSE2 or LRIG2</i> (<a class="figpopup" href="/books/NBK154138/table/urofacial.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figurofacialTmoleculargenetictestingus" rid-ob="figoburofacialTmoleculargenetictestingus">Table 1</a>)</div><div class="half_rhythm">Note that the majority of individuals with UFS reported to date have not had molecular confirmation of their diagnosis.</div></li></ul><p>Molecular genetic testing approaches can include <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (serial single-gene testing) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> or <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>).</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Individuals with the distinctive findings described in <a href="#urofacial.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#urofacial.Option_1">Option 1</a>), whereas those in whom the diagnosis of UFS has not been considered due to the overlap of the urinary tract features of UFS with other disorders of the lower urinary tract and lack of recognition of the characteristic facial expression are more likely to be diagnosed using genomic testing (see <a href="#urofacial.Option_2">Option 2</a>).</p><div id="urofacial.Option_1"><h4>Option 1</h4><p>When the phenotypic findings suggest the diagnosis of UFS, serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing is typically used.</p><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>HPSE2</i> first; if only one or no pathogenic variants are identified perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications. If testing of <i>HPSE2</i> is nondiagnostic, perform sequence analysis of <i>LRIG2.</i></p></div><div id="urofacial.Option_2"><h4>Option 2</h4><p>When the diagnosis of UFS has not been considered, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option [<a class="bk_pop" href="#urofacial.REF.vivante.2017.69">Vivante et al 2017</a>]. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p><b>Exome array</b> (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is nondiagnostic.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="urofacial.T.molecular_genetic_testing_us" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Urofacial Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK154138/table/urofacial.T.molecular_genetic_testing_us/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__urofacial.T.molecular_genetic_testing_us_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of UFS Attributed to Pathogenic Variants in This Gene&#x000a0;<sup>3</sup></th><th id="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>4</sup> Detectable by Test Method</th></tr><tr><th headers="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_3" id="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>5</sup></th><th headers="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_3" id="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></th></tr></thead><tbody><tr><td headers="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HPSE2</i></td><td headers="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17/25</td><td headers="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_3 hd_h_urofacial.T.molecular_genetic_testing_us_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">16/17&#x000a0;<sup>7</sup></td><td headers="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_3 hd_h_urofacial.T.molecular_genetic_testing_us_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 family&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LRIG2</i></td><td headers="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4/25</td><td headers="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_3 hd_h_urofacial.T.molecular_genetic_testing_us_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4/4&#x000a0;<sup>9</sup></td><td headers="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_3 hd_h_urofacial.T.molecular_genetic_testing_us_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported</td></tr><tr><td headers="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4/25</td><td headers="hd_h_urofacial.T.molecular_genetic_testing_us_1_1_1_3 hd_h_urofacial.T.molecular_genetic_testing_us_1_1_2_1 hd_h_urofacial.T.molecular_genetic_testing_us_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="urofacial.TF.1.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="urofacial.TF.1.2"><p class="no_margin">See <a href="/books/NBK154138/#urofacial.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="urofacial.TF.1.3"><p class="no_margin"><a class="bk_pop" href="#urofacial.REF.stuart.2013.259">Stuart et al [2013]</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2015.797">Stuart et al [2015]</a></p></div></dd><dt>4. </dt><dd><div id="urofacial.TF.1.4"><p class="no_margin">See <a href="#urofacial.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>5. </dt><dd><div id="urofacial.TF.1.5"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>6. </dt><dd><div id="urofacial.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="urofacial.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#urofacial.REF.daly.2010.963">Daly et al [2010]</a>, <a class="bk_pop" href="#urofacial.REF.pang.2010.957">Pang et al [2010]</a>, <a class="bk_pop" href="#urofacial.REF.al_badr.2011.569">Al Badr et al [2011]</a>, <a class="bk_pop" href="#urofacial.REF.mahmood.2012.88">Mahmood et al [2012]</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2015.797">Stuart et al [2015]</a></p></div></dd><dt>8. </dt><dd><div id="urofacial.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#urofacial.REF.daly.2010.963">Daly et al [2010]</a></p></div></dd><dt>9. </dt><dd><div id="urofacial.TF.1.9"><p class="no_margin">Note: A large Alu <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> resulting in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> skipping has been reported [<a class="bk_pop" href="#urofacial.REF.stuart.2013.259">Stuart et al 2013</a>].</p></div></dd></dl></div></div></div></div></div></div><div id="urofacial.Clinical_Characteristics"><h2 id="_urofacial_Clinical_Characteristics_">Clinical Characteristics</h2><div id="urofacial.Clinical_Description"><h3>Clinical Description</h3><p>The main features of urofacial syndrome (UFS) are <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> urinary bladder voiding dysfunction and an abnormality of facial movement with expression that can be observed from birth. Bowel dysfunction is common. In rare instances, an individual who has: (a) a molecularly confirmed diagnosis; and/or (b) an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> relative meeting clinical diagnostic criteria manifests only the characteristic facial features or only the urinary bladder voiding dysfunction (not both).</p><p>Significant inter- and intrafamilial phenotypic variability has been observed [<a class="bk_pop" href="#urofacial.REF.ochoa.1992.580">Ochoa 1992</a>, <a class="bk_pop" href="#urofacial.REF.aydogdu.2010.431">Aydogdu et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2013.259">Stuart et al 2013</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2015.797">Stuart et al 2015</a>].</p><p>Urinary tract features are the main reason for presenting to medical attention and the main cause of associated morbidity and mortality.</p><p>UFS is not associated with growth or developmental abnormality other than that attributable to chronic renal disease. Intellect is normal.</p><p><b>Urinary tract.</b> Urinary tract features have been present in all but two of more than 150 clinically defined individuals [<a class="bk_pop" href="#urofacial.REF.aydogdu.2010.431">Aydogdu et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2013.259">Stuart et al 2013</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2015.797">Stuart et al 2015</a>].</p><p>Antenatal ultrasound examination (if performed) is frequently described as abnormal and is associated with megacystis, hydroureteronephrosis, and renal pelvis dilatation [<a class="bk_pop" href="#urofacial.REF.sk_lov_.2006.125">Sk&#x000e1;lov&#x000e1; et al 2006</a>, <a class="bk_pop" href="#urofacial.REF.bacchetta.2010.225">Bacchetta &#x00026; Cochat 2010</a>, <a class="bk_pop" href="#urofacial.REF.daly.2010.963">Daly et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2013.259">Stuart et al 2013</a>].</p><p>Severe neonatal and infant presentations with urinary tract complications including urinary bladder rupture and sepsis have been reported [<a class="bk_pop" href="#urofacial.REF.ochoa.1992.580">Ochoa 1992</a>, <a class="bk_pop" href="#urofacial.REF.sk_lov_.2006.125">Sk&#x000e1;lov&#x000e1; et al 2006</a>].</p><p>More typical presentations of urinary tract features include recurrent urinary sepsis and failure to achieve urinary continence [<a class="bk_pop" href="#urofacial.REF.ochoa.1992.580">Ochoa 1992</a>, <a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>].</p><p>In the Ochoa cohort hydroureteronephrosis was found in 29/50 (58%) of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#urofacial.REF.ochoa.1992.580">Ochoa 1992</a>, <a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>], a finding consistent with the range of urinary tract abnormalities in other case reports [<a class="bk_pop" href="#urofacial.REF.chauve.2000.10">Chauve et al 2000</a>, <a class="bk_pop" href="#urofacial.REF.garciaminaur.2001.165">Garcia-Minaur et al 2001</a>, <a class="bk_pop" href="#urofacial.REF.alqahtani.2003.61">Al-Qahtani 2003</a>, <a class="bk_pop" href="#urofacial.REF.nicanor.2005.477">Nicanor et al 2005</a>, <a class="bk_pop" href="#urofacial.REF.sk_lov_.2006.125">Sk&#x000e1;lov&#x000e1; et al 2006</a>, <a class="bk_pop" href="#urofacial.REF.derbent.2009.589">Derbent et al 2009</a>, <a class="bk_pop" href="#urofacial.REF.aydogdu.2010.431">Aydogdu et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.daly.2010.963">Daly et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.stamatiou.2010.582">Stamatiou &#x00026; Karakos 2010</a>, <a class="bk_pop" href="#urofacial.REF.sutay.2010.445">Sutay et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.al_badr.2011.569">Al Badr et al 2011</a>, <a class="bk_pop" href="#urofacial.REF.akl.2012.346">Akl &#x00026; Al Momany 2012</a>, <a class="bk_pop" href="#urofacial.REF.mahmood.2012.88">Mahmood et al 2012</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2013.259">Stuart et al 2013</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2015.797">Stuart et al 2015</a>].</p><p><a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa [2004]</a> identified vesicoureteric reflux in 32/50 (64%); reflux was bilateral in 18 (36%).</p><p>The associated renal parenchymal damage with early impairment of renal function and progression to end-stage renal disease causes substantial morbidity and mortality [<a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>, <a class="bk_pop" href="#urofacial.REF.sk_lov_.2006.125">Sk&#x000e1;lov&#x000e1; et al 2006</a>, <a class="bk_pop" href="#urofacial.REF.sutay.2010.445">Sutay et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.mahmood.2012.88">Mahmood et al 2012</a>]. The proportion of individuals who develop renal impairment is unknown but likely to be significant [<a class="bk_pop" href="#urofacial.REF.ochoa.1987.661">Ochoa &#x00026; Gorlin 1987</a>, <a class="bk_pop" href="#urofacial.REF.ochoa.1992.580">Ochoa 1992</a>, <a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>, <a class="bk_pop" href="#urofacial.REF.aydogdu.2010.431">Aydogdu et al 2010</a>].</p><p><b>Facial expression.</b> The most prominent facial feature, abnormal co-contraction of the corners of the mouth and eyes, is most obvious during smiling or laughing [<a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>, <a class="bk_pop" href="#urofacial.REF.aydogdu.2010.431">Aydogdu et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.ganesan.2011.507">Ganesan &#x00026; Thomas 2011</a>] and can be socially debilitating.</p><p>Symmetric partial facial paresis in the distribution of the facial nerve has been noted; however, the proportion of individuals in whom weakness is a significant feature is unknown [<a class="bk_pop" href="#urofacial.REF.garciaminaur.2001.165">Garcia-Minaur et al 2001</a>; Author, personal observation].</p><p>Abnormal facial movement with crying has been observed as early as the neonatal period [<a class="bk_pop" href="#urofacial.REF.ochoa.1992.580">Ochoa 1992</a>, <a class="bk_pop" href="#urofacial.REF.sk_lov_.2006.125">Sk&#x000e1;lov&#x000e1; et al 2006</a>].</p><p>Nocturnal lagophthalmos (incomplete closing of the eyes during sleep) appears to be a common and significant finding that may lead to keratitis, corneal abrasion, infection, vascularization, and in extreme cases, ocular perforation, endophthalmitis, and loss of the eye [<a class="bk_pop" href="#urofacial.REF.mermerkaya.2014.661">Mermerkaya et al 2014</a>].</p><p>Typical facial expressions have been present in all but one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual (who was diagnosed due to classic features in a relative) [<a class="bk_pop" href="#urofacial.REF.aydogdu.2010.431">Aydogdu et al 2010</a>].</p><p>Rarely, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may have a facial <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> with no urinary bladder dysfunction or symptoms [<a class="bk_pop" href="#urofacial.REF.stuart.2013.259">Stuart et al 2013</a>; Author, personal communication].</p><p><b>Gastrointestinal tract.</b> Constipation is reported in about 66% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals; encopresis is present in 33% [<a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>].</p><p>Fecal retention in the neonatal period has been noted once [<a class="bk_pop" href="#urofacial.REF.nicanor.2005.477">Nicanor et al 2005</a>].</p><p>Rectal prolapse has also been reported once in association with severe constipation [<a class="bk_pop" href="#urofacial.REF.al_badr.2011.569">Al Badr et al 2011</a>].</p><p><b>MRI of the central nervous system (CNS)</b> &#x02013; performed because the urinary tract features mimic those associated with CNS dysfunction &#x02013; is typically normal [<a class="bk_pop" href="#urofacial.REF.nicanor.2005.477">Nicanor et al 2005</a>, <a class="bk_pop" href="#urofacial.REF.derbent.2009.589">Derbent et al 2009</a>, <a class="bk_pop" href="#urofacial.REF.aydogdu.2010.431">Aydogdu et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.al_badr.2011.569">Al Badr et al 2011</a>, <a class="bk_pop" href="#urofacial.REF.akl.2012.346">Akl &#x00026; Al Momany 2012</a>].</p><p>UFS most likely results from an abnormality of peripheral rather than central nervous system development [<a class="bk_pop" href="#urofacial.REF.roberts.2014.4302">Roberts et al 2014</a>], although <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals do not typically show any other features of neurologic dysfunction.</p><p>Note: Although early descriptions of UFS reported individuals with central nervous system abnormalities including spina bifida occulta, occipital meningocele, and hydrocephalus due to stenosis of the aqueduct of Sylvius, the subsequent failure to identify these findings indicates that they were most likely chance associations [<a class="bk_pop" href="#urofacial.REF.elejalde.1979.97">Elejalde 1979</a>, <a class="bk_pop" href="#urofacial.REF.teebi.1991.199">Teebi &#x00026; Hassoon 1991</a>].</p></div><div id="urofacial.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been reported.</p></div><div id="urofacial.Prevalence"><h3>Prevalence</h3><p>UFS is rare. Its prevalence is currently unknown but is likely to be higher in certain populations &#x02013; for example, in Colombia as the result of a <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> and associated <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> [<a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>, <a class="bk_pop" href="#urofacial.REF.pang.2010.957">Pang et al 2010</a>].</p></div></div><div id="urofacial.Genetically_Related_Allelic_Di"><h2 id="_urofacial_Genetically_Related_Allelic_Di_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>HPSE2</i> or <i>LRIG2</i>.</p></div><div id="urofacial.Differential_Diagnosis"><h2 id="_urofacial_Differential_Diagnosis_">Differential Diagnosis</h2><p>The urinary tract features of urofacial syndrome (UFS) overlap with those seen in association with multiple other conditions [<a class="bk_pop" href="#urofacial.REF.woolf.2014a.353">Woolf et al 2014a</a>].</p><p><b>Antenatal or <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> megacystis and/or hydronephrosis</b></p><ul><li class="half_rhythm"><div>Urethral obstruction due to posterior urethral valves or atresia</div></li><li class="half_rhythm"><div>Chromosome abnormalities (e.g., megacystis in association with trisomy 21 and 13)</div></li><li class="half_rhythm"><div>Prune belly sequence (e.g., caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CHRM3</i> [<a class="bk_pop" href="#urofacial.REF.weber.2011.668">Weber et al 2011</a>])</div></li><li class="half_rhythm"><div>Megacystis microcolon intestinal hypoperistalsis syndrome, a heterogeneous condition resulting from smooth muscle dysfunction caused by <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> variants in:</div><ul><li class="half_rhythm"><div><i>ACTA2</i> (encoding &#x003b1;-smooth muscle actin) [<a class="bk_pop" href="#urofacial.REF.richer.2012.664">Richer et al 2012</a>]</div></li><li class="half_rhythm"><div><i>ACTG2</i> (encoding &#x003b3;2-smooth muscle actin) (see <a href="/books/n/gene/actg2-dis/"><i>ACTG2</i>-Related Disorders</a>)</div></li></ul><div>OR <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> variants in:</div><ul><li class="half_rhythm"><div><i>LMOD1</i> (encoding leiomodin1) [<a class="bk_pop" href="#urofacial.REF.halim.2017b.e2739">Halim et al 2017b</a>]</div></li><li class="half_rhythm"><div><i>MYH11</i> (encoding myosin light chain kinase) [<a class="bk_pop" href="#urofacial.REF.gauthier.2015.1266">Gauthier et al 2015</a>]</div></li><li class="half_rhythm"><div><i>MYLK</i> (encoding myosin light chain kinase) [<a class="bk_pop" href="#urofacial.REF.halim.2017a.123">Halim et al 2017a</a>]</div></li><li class="half_rhythm"><div><i>MYL9</i> (encoding myosin light chain 9) [<a class="bk_pop" href="#urofacial.REF.moreno.2018.669">Moreno et al 2018</a>]</div></li></ul></li></ul><p><b>Urinary bladder voiding dysfunction</b></p><ul><li class="half_rhythm"><div>Neuropathic bladder (e.g., due to a neurologic lesion such as spina bifida)</div></li><li class="half_rhythm"><div>Voiding dysfunction of unclear etiology, variably termed occult neuropathic bladder, subclinical neuropathic bladder, non-neurogenic neurogenic bladder, and Hinman-Allen syndrome</div></li></ul><p><b>Vesicoureteric reflux</b></p><ul><li class="half_rhythm"><div>Common in the general population</div></li><li class="half_rhythm"><div>May be <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and is genetically heterogeneous</div></li></ul></div><div id="urofacial.Management"><h2 id="_urofacial_Management_">Management</h2><div id="urofacial.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with urofacial syndrome (UFS), the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Urinalysis and urine culture for occult or chronic infection</div></li><li class="half_rhythm"><div>Assessment of renal function: serum creatinine concentration and/or estimated glomerular filtration rate</div></li><li class="half_rhythm"><div>Urinary tract ultrasound examination</div></li><li class="half_rhythm"><div>Micturating cystourethrogram</div></li><li class="half_rhythm"><div>Uroflowmetry or urodynamic testing</div></li><li class="half_rhythm"><div>Blood pressure measurement</div></li><li class="half_rhythm"><div>Assessment of renal parenchymal damage: as indicated by the individual's presentation, dimercaptosuccinic acid (DMSA) isotope scan to visualize functional kidney parenchyma [<a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>, <a class="bk_pop" href="#urofacial.REF.aydogdu.2010.431">Aydogdu et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2013.259">Stuart et al 2013</a>]</div></li><li class="half_rhythm"><div>Assessment of bowel emptying</div></li><li class="half_rhythm"><div>Ophthalmologic examination for evidence of nocturnal lagophthalmos</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="urofacial.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Urinary tract.</b> No evidence-based guidelines exist for treatment of the urinary tract abnormalities of UFS.</p><p>Urinary tract infections warrant rapid and complete treatment. Urosepsis should be treated as per the general population with antibiotic use directed by culture; antibiotic prophylaxis may also be considered.</p><p>Anticholinergic and &#x003b1;<sub>1</sub>-adrenergic blockers have been used in the medical management of urinary incontinence and bladder dysfunction [<a class="bk_pop" href="#urofacial.REF.aydogdu.2010.431">Aydogdu et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2013.259">Stuart et al 2013</a>].</p><p>Intermittent catheterization or vesicostomy to reduce residual urine volumes and achieve continence with a reduced risk of infections have been used.</p><p>Surgical management of hydroureteronephrosis and bladder augmentation to slow progression of renal impairment have been used; their efficacy is not known [<a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2013.259">Stuart et al 2013</a>].</p><p>Early recognition of renal impairment should prompt initiation of intensive management to prevent or slow progression. Renal impairment and hypertension are managed as per clinical status. Successful renal transplantation has been reported [<a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>].</p><p><b>Bowel.</b> Constipation is managed as for the general population.</p><p><b>Nocturnal lagophthalmos</b> requires lubricant drops during the day and ointments at night to protect the cornea from exposure keratopathy (typically under the care of an ophthalmologist) [<a class="bk_pop" href="#urofacial.REF.mermerkaya.2014.661">Mermerkaya et al 2014</a>].</p></div><div id="urofacial.Surveillance"><h3>Surveillance</h3><p>Monitor:</p><ul><li class="half_rhythm"><div>For evidence of urinary tract features including vesicoureteric reflux and hydroureteronephrosis;</div></li><li class="half_rhythm"><div>Renal function at intervals determined by urinary tract features at presentation and their subsequent progression;</div></li><li class="half_rhythm"><div>For evidence of significant corneal involvement in individuals with nocturnal lagophthalmos.</div></li></ul></div><div id="urofacial.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Nephrotoxic substances contraindicated in individuals with renal impairment should be avoided if possible.</p></div><div id="urofacial.Evaluation_of_Relatives_at_Ris"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic/clinical status of sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual as soon as possible after birth in order to identify those who would benefit from prompt evaluation of the urinary tract and renal function and early initiation of necessary treatment.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the pathogenic variants in the family are known;</div></li><li class="half_rhythm"><div>Examination to determine whether facial and/or urinary tract manifestations of UFS are present if the pathogenic variants in the family are not known.</div></li></ul><p>See <a href="#urofacial.Related_Genetic_Counseling_Iss">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="urofacial.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Although no guidelines for prenatal management of UFS exist, it seems appropriate to perform ultrasound examination of pregnancies at risk to determine if urinary tract involvement of UFS is present, as it may influence the timing and/or location of delivery (e.g., in a tertiary medical center that could manage renal/urinary complications immediately after birth).</p></div><div id="urofacial.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="urofacial.Genetic_Counseling"><h2 id="_urofacial_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="urofacial.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Urofacial syndrome (UFS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="urofacial.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one UFS-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with <i>HPSE2</i>-related or <i>LRIG2</i>-related UFS are obligate heterozygotes for an <i>HPSE2</i> or <i>LRIG2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, respectively (i.e., all offspring are carriers of a pathogenic variant inherited from their parent).</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a UFS-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="urofacial.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the UFS-related pathogenic variants in the family.</p></div><div id="urofacial.Related_Genetic_Counseling_Iss"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#urofacial.Evaluation_of_Relatives_at_Ris">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="urofacial.Prenatal_Testing_and_Preimplan"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the UFS-related pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p><b>Fetal ultrasonography.</b> In families at risk of having an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child, prenatal ultrasound of the urinary tract may show megacystis, hydroureteronephrosis, or renal pelvis dilatation in an affected pregnancy. These features are not specific for UFS.</p></div></div><div id="urofacial.Resources"><h2 id="_urofacial_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Genetic and Rare Diseases Information Center (GARD)</b></div><div><a href="https://rarediseases.info.nih.gov/diseases/104/index" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ochoa syndrome</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition/ochoa-syndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ochoa Syndrome</a></div></li></ul></div><div id="urofacial.Molecular_Genetics"><h2 id="_urofacial_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="urofacial.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Urofacial Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK154138/table/urofacial.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__urofacial.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_urofacial.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_urofacial.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_urofacial.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_urofacial.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_urofacial.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_urofacial.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_urofacial.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/60495" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>HPSE2</i></a></td><td headers="hd_b_urofacial.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=60495" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10q24<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_urofacial.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8WWQ2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Inactive heparanase-2</a></td><td headers="hd_b_urofacial.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/HPSE2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPSE2 database</a></td><td headers="hd_b_urofacial.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=HPSE2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPSE2</a></td><td headers="hd_b_urofacial.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=HPSE2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPSE2</a></td></tr><tr><td headers="hd_b_urofacial.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/9860" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>LRIG2</i></a></td><td headers="hd_b_urofacial.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=9860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p13<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_urofacial.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O94898" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Leucine-rich repeats and immunoglobulin-like domains protein 2</a></td><td headers="hd_b_urofacial.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_urofacial.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=LRIG2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LRIG2</a></td><td headers="hd_b_urofacial.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=LRIG2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LRIG2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="urofacial.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="urofacial.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Urofacial Syndrome (<a href="/omim/236730,608869,613469,615112" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK154138/table/urofacial.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__urofacial.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/236730" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">236730</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">UROFACIAL SYNDROME 1; UFS1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608869" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608869</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 2; LRIG2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613469" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613469</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HEPARANASE 2; HPSE2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615112" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615112</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">UROFACIAL SYNDROME 2; UFS2</td></tr></tbody></table></div></div><div id="urofacial.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>The molecular pathogenesis of urofacial syndrome (UFS) is not currently understood. It had previously been speculated that the features of UFS could result from a central nervous system abnormality [<a class="bk_pop" href="#urofacial.REF.ochoa.2004.6">Ochoa 2004</a>]. However, it is now considered more likely that UFS represents an abnormality of peripheral neurodevelopment or function [<a class="bk_pop" href="#urofacial.REF.ganesan.2011.507">Ganesan &#x00026; Thomas 2011</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2013.259">Stuart et al 2013</a>, <a class="bk_pop" href="#urofacial.REF.roberts.2014.4302">Roberts et al 2014</a>, <a class="bk_pop" href="#urofacial.REF.woolf.2014b.513">Woolf et al 2014b</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2015.797">Stuart et al 2015</a>].</p><p>Both <i>HPSE2</i> and its encoded protein (heparanase 2) and <i>LRIG2</i> and its encoded protein (the leucine-rich repeats and immunoglobulin-like domains 2, or LRIG2) are expressed and localize to the peripheral nervous system, including the developing nerves of the fetal bladder [<a class="bk_pop" href="#urofacial.REF.mckenzie.2000.1170">McKenzie et al 2000</a>, <a class="bk_pop" href="#urofacial.REF.guo.2004.157">Guo et al 2004</a>, <a class="bk_pop" href="#urofacial.REF.homma.2009.1">Homma et al 2009</a>, <a class="bk_pop" href="#urofacial.REF.daly.2010.963">Daly et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2013.259">Stuart et al 2013</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2015.797">Stuart et al 2015</a>].</p><p>While the functions of heparanase 2 and LRIG2 are not fully understood, current knowledge suggests that they have a role in regulating growth factor signaling [<a class="bk_pop" href="#urofacial.REF.hedman.2007.676">Hedman &#x00026; Henriksson 2007</a>; <a class="bk_pop" href="#urofacial.REF.fux.2009.511">Fux et al 2009</a>; <a class="bk_pop" href="#urofacial.REF.levyadam.2010.28010">Levy-Adam et al 2010</a>; <a class="bk_pop" href="#urofacial.REF.pang.2010.957">Pang et al 2010</a>; <a class="bk_pop" href="#urofacial.REF.cui.2011.273">Cui et al 2011</a>; Author, personal communication].</p><div id="urofacial.HPSE2"><h4><i>HPSE2</i></h4><p><b>Gene structure.</b>
<i>HPSE2</i> is expressed as three protein-coding <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> transcripts resulting from alternate <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of 12 exons [<a class="bk_pop" href="#urofacial.REF.mckenzie.2000.1170">McKenzie et al 2000</a>]. The variant transcript encoding the longest protein <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> is <a href="/nuccore/NM_021828.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_021828.4</a>. See <a href="/books/NBK154138/#urofacial.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> Pathogenic changes resulting in presumed loss of function include frameshift and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions, and, in one instance, a pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant [<a class="bk_pop" href="#urofacial.REF.daly.2010.963">Daly et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.pang.2010.957">Pang et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.al_badr.2011.569">Al Badr et al 2011</a>, <a class="bk_pop" href="#urofacial.REF.mahmood.2012.88">Mahmood et al 2012</a>, <a class="bk_pop" href="#urofacial.REF.stuart.2015.797">Stuart et al 2015</a>].</p><p>Pathogenic variants have been found throughout <i>HPSE2</i> with no mutational hot spots.</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> c.1516C&#x0003e;T in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 11 has been identified in the Colombian population [<a class="bk_pop" href="#urofacial.REF.pang.2010.957">Pang et al 2010</a>].</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> c.1465_1466delAA in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 10 has been found in individuals of Irish ancestry [<a class="bk_pop" href="#urofacial.REF.daly.2010.963">Daly et al 2010</a>, <a class="bk_pop" href="#urofacial.REF.pang.2010.957">Pang et al 2010</a>].</p><div id="urofacial.T.hpse2_pathogenic_variants_di" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>HPSE2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK154138/table/urofacial.T.hpse2_pathogenic_variants_di/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__urofacial.T.hpse2_pathogenic_variants_di_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_urofacial.T.hpse2_pathogenic_variants_di_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_urofacial.T.hpse2_pathogenic_variants_di_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_urofacial.T.hpse2_pathogenic_variants_di_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_urofacial.T.hpse2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1465_1466delAA</td><td headers="hd_h_urofacial.T.hpse2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn489ProfsTer126</td><td headers="hd_h_urofacial.T.hpse2_pathogenic_variants_di_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_021828.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_021828<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_068600.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_068600<wbr style="display:inline-block"></wbr>​.4</a></td></tr><tr><td headers="hd_h_urofacial.T.hpse2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1516C&#x0003e;T</td><td headers="hd_h_urofacial.T.hpse2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg506Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>HPSE2</i> encodes heparanase 2 and has three <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> of 592 (<a href="/protein/NP_068600.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_068600.4</a>), 534 (<a href="/protein/NP_001159716.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001159716.1</a>), and 480 (<a href="/protein/NP_001159717.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001159717.1</a>) amino acids. Heparanase 2 shows 35% identity with heparanase 1, which is highest over their shared heparan sulfate binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#urofacial.REF.mckenzie.2000.1170">McKenzie et al 2000</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The mechanism by which loss of heparanase 2 results in disease is currently unknown.</p></div><div id="urofacial.LRIG2"><h4><i>LRIG2</i></h4><p><b>Gene structure.</b>
<i>LRIG2</i> is expressed as five <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> variants from alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of 18 exons [<a class="bk_pop" href="#urofacial.REF.holmlund.2004.35">Holmlund et al 2004</a>]. One variant is protein coding (<a href="/nuccore/NM_014813.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_014813.1</a>). See <a href="/books/NBK154138/#urofacial.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> To date the few pathogenic changes that have been identified are presumed to be <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a>; they include frameshift and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants and a large Alu <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> resulting in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> skipping [<a class="bk_pop" href="#urofacial.REF.stuart.2013.259">Stuart et al 2013</a>, <a class="bk_pop" href="#urofacial.REF.fadda.2016.84">Fadda et al 2016</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>LRIG2</i> encodes the 1,065-amino-acid protein leucine-rich repeats and immunoglobulin-like domains protein 2 (LRIG2) [<a class="bk_pop" href="#urofacial.REF.holmlund.2004.35">Holmlund et al 2004</a>] (<a href="/protein/NP_055628.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_055628.1</a>). LRIG2 shows about 50% identity to the homologs LRIG 1 and 3 [<a class="bk_pop" href="#urofacial.REF.guo.2004.157">Guo et al 2004</a>]. The family has a common <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> structure of a signal peptide, 15 tandem leucine-rich repeats (LRR) with cysteine-rich N- and C-flanking domains, three immunoglobulin-like (Ig-like) domains, a transmembrane domain, and a cytoplasmic tail [<a class="bk_pop" href="#urofacial.REF.nilsson.2001.1155">Nilsson et al 2001</a>, <a class="bk_pop" href="#urofacial.REF.guo.2004.157">Guo et al 2004</a>, <a class="bk_pop" href="#urofacial.REF.holmlund.2004.35">Holmlund et al 2004</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The mechanism by which loss of LRIG2 results in disease is currently unknown.</p></div></div></div><div id="urofacial.References"><h2 id="_urofacial_References_">References</h2><div id="urofacial.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.akl.2012.346">Akl KF, Al Momany HM. Urofacial syndrome. <span><span class="ref-journal">Saudi J Kidney Dis Transpl. </span>2012;<span class="ref-vol">23</span>:346–8.</span> [<a href="/pubmed/22382233" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22382233</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.al_badr.2011.569">Al Badr W, Al Bader S, Otto E, Hildebrandt F, Ackley T, Peng W, Xu J, Li J, Owens KM, Bloom D, Innis JW. Exome capture and massively parallel sequencing identifies a novel HPSE2 mutation in a Saudi Arabian child with Ochoa (urofacial) syndrome. <span><span class="ref-journal">J Pediatr Urol. </span>2011;<span class="ref-vol">7</span>:569–73.</span> [<a href="/pmc/articles/PMC3157539/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3157539</span></a>] [<a href="/pubmed/21450525" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21450525</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.alqahtani.2003.61">Al-Qahtani FN. Ochoa syndrome: new features. <span><span class="ref-journal">Saudi J Kidney Dis Transpl. </span>2003;<span class="ref-vol">14</span>:61–4.</span> [<a href="/pubmed/17657091" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17657091</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.aydogdu.2010.431">Aydogdu O, Burgu B, Demirel F, Soygur T, Ozcakar ZB, Yalcinkaya F, Tekgul S. Ochoa syndrome: a spectrum of urofacial syndrome. <span><span class="ref-journal">Eur J Pediatr. </span>2010;<span class="ref-vol">169</span>:431–5.</span> [<a href="/pubmed/19669792" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19669792</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.bacchetta.2010.225">Bacchetta J, Cochat P. Severe voiding dysfunction: ask the child to smile. <span><span class="ref-journal">Kidney Int. </span>2010;<span class="ref-vol">78</span>:225–6.</span> [<a href="/pubmed/20588289" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20588289</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.chauve.2000.10">Chauve X, Missirian C, Malzac P, Girardot L, Guys JM, Louis C, Philip N, Voelckel MA. Genetic homogeneity of the urofacial (Ochoa) syndrome confirmed in a new French family. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">95</span>:10–2.</span> [<a href="/pubmed/11074487" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11074487</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.cui.2011.273">Cui H, Shao C, Liu Q, Yu W, Fang J, Yu W, Ali A, Ding K. Heparanase enhances nerve-growth-factor-induced PC12 cell neuritogenesis via the p38 MAPK pathway. <span><span class="ref-journal">Biochem J. </span>2011;<span class="ref-vol">440</span>:273–82.</span> [<a href="/pubmed/21831044" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21831044</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.daly.2010.963">Daly SB, Urquhart JE, Hilton E, McKenzie EA, Kammerer RA, Lewis M, Kerr B, Stuart H, Donnai D, Long DA, Burgu B, Aydogdu O, Derbent M, Garcia-Minaur S, Reardon W, Gener B, Shalev S, Smith R, Woolf AS, Black GC, Newman WG. Mutations in HPSE2 cause urofacial syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">86</span>:963–9.</span> [<a href="/pmc/articles/PMC3032078/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3032078</span></a>] [<a href="/pubmed/20560210" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20560210</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.derbent.2009.589">Derbent M, Melek E, Arman A, U&#x000e7;kan S, Baskin E. Urofacial (Ochoa) syndrome: can a facial gestalt represent severe voiding dysfunction? <span><span class="ref-journal">Ren Fail. </span>2009;<span class="ref-vol">31</span>:589–92.</span> [<a href="/pubmed/19839856" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19839856</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.elejalde.1979.97">Elejalde BR. Genetic and diagnostic considerations in three families with abnormalities of facial expression and congenital urinary obstruction: "The Ochoa syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1979;<span class="ref-vol">3</span>:97–108.</span> [<a href="/pubmed/474623" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 474623</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.fadda.2016.84">Fadda A, Butt F, Tomei S, Deola S, Lo B, Robay A, Al-Shakaki A, Al-Hajri N, Crystal R, Kambouris M, Wang E, Marincola FM, Fakhro KA, Cugno C. Two hits in one: whole genome sequencing unveils LIG4 syndrome and urofacial syndrome in a case report of a child with complex phenotype. <span><span class="ref-journal">BMC Med Genet. </span>2016;<span class="ref-vol">17</span>:84.</span> [<a href="/pmc/articles/PMC5114772/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5114772</span></a>] [<a href="/pubmed/27855655" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27855655</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.feldman.2006.139">Feldman AS, Bauer SB. Diagnosis and management of dysfunctional voiding. <span><span class="ref-journal">Curr Opin Pediatr. </span>2006;<span class="ref-vol">18</span>:139–47.</span> [<a href="/pubmed/16601493" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16601493</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.fux.2009.511">Fux L, Ilan N, Sanderson RD, Vlodavsky I. Heparanase: busy at the cell surface. <span><span class="ref-journal">Trends Biochem Sci. </span>2009;<span class="ref-vol">34</span>:511–9.</span> [<a href="/pmc/articles/PMC2755511/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2755511</span></a>] [<a href="/pubmed/19733083" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19733083</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.ganesan.2011.507">Ganesan I, Thomas T. More than meets the smile: facial muscle expression in children with Ochoa syndrome. <span><span class="ref-journal">Med J Malaysia. </span>2011;<span class="ref-vol">66</span>:507–9.</span> [<a href="/pubmed/22390114" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22390114</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.garciaminaur.2001.165">Garcia-Minaur S, Oliver F, Yanez JM, Soriano JR, Quinn F, Reardon W. Three new European cases of urofacial (Ochoa) syndrome. <span><span class="ref-journal">Clin Dysmorphol. </span>2001;<span class="ref-vol">10</span>:165–70.</span> [<a href="/pubmed/11446407" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11446407</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.gauthier.2015.1266">Gauthier J, Ouled Amar Bencheikh B, Hamdan FF, Harrison SM, Baker LA, Couture F, Thiffault I, Ouazzani R, Samuels ME, Mitchell GA, Rouleau GA, Michaud JL, Soucy JF. A homozygous loss-of-function variant in MYH11 in a case with megacystis-microcolon-intestinal hypoperistalsis syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2015;<span class="ref-vol">23</span>:1266–8.</span> [<a href="/pmc/articles/PMC4538215/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4538215</span></a>] [<a href="/pubmed/25407000" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25407000</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.guo.2004.157">Guo D, Holmlund C, Henriksson R, Hedman H. The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea. <span><span class="ref-journal">Genomics. </span>2004;<span class="ref-vol">84</span>:157–65.</span> [<a href="/pubmed/15203213" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15203213</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.halim.2017a.123">Halim D, Brosens E, Muller F, Wangler MF, Beaudet AL, Lupski JR, Akdemir ZHC, Doukas M, Stoop HJ, de Graaf BM, Brouwer RWW, van Ijcken WFJ, Oury JF, Rosenblatt J, Burns AJ, Tibboel D, Hofstra RMW, Alves MM. Loss-of-function variants in MYLK cause recessive megacystis microcolon intestinal hypoperistalsis syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2017a;<span class="ref-vol">101</span>:123–9.</span> [<a href="/pmc/articles/PMC5501771/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5501771</span></a>] [<a href="/pubmed/28602422" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28602422</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.halim.2017b.e2739">Halim D, Wilson MP, Oliver D, Brosens E, Verheij JB, Han Y, Nanda V, Lyu Q, Doukas M, Stoop H, Brouwer RW, van IJcken WF, Slivano OJ, Burns AJ, Christie CK, de Mesy Bentley KL, Brooks AS, Tibboel D, Xu S, Jin ZG, Djuwantono T, Yan W, Alves MM, Hofstra RM, Miano JM. Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2017b;<span class="ref-vol">114</span>:E2739–E2747.</span> [<a href="/pmc/articles/PMC5380076/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5380076</span></a>] [<a href="/pubmed/28292896" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28292896</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.hedman.2007.676">Hedman H, Henriksson R. LRIG inhibitors of growth factor signalling - double-edged swords in human cancer? <span><span class="ref-journal">Eur J Cancer. </span>2007;<span class="ref-vol">43</span>:676–82.</span> [<a href="/pubmed/17239582" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17239582</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.holmlund.2004.35">Holmlund C, Nilsson J, Guo D, Starefeldt A, Golovleva I, Henriksson R, Hedman H. Characterization and tissue-specific expression of human LRIG2. <span><span class="ref-journal">Gene. </span>2004;<span class="ref-vol">332</span>:35–43.</span> [<a href="/pubmed/15145052" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15145052</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.homma.2009.1">Homma S, Shimada T, Hikake T, Yaginuma H. Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryo. <span><span class="ref-journal">Gene Expr Patterns. </span>2009;<span class="ref-vol">9</span>:1–26.</span> [<a href="/pubmed/18848646" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18848646</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.levyadam.2010.28010">Levy-Adam F, Feld S, Cohen-Kaplan V, Shteingauz A, Gross M, Arvatz G, Naroditsky I, Ilan N, Doweck I, Vlodavsky I. Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity. <span><span class="ref-journal">J Biol Chem. </span>2010;<span class="ref-vol">285</span>:28010–9.</span> [<a href="/pmc/articles/PMC2934666/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2934666</span></a>] [<a href="/pubmed/20576607" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20576607</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.mahmood.2012.88">Mahmood S, Beetz C, Tahir MM, Imran M, Mumtaz R, Bassmann I, Jahic A, Malik M, N&#x000fc;rnberg G, Hassan SA, Rana S, N&#x000fc;rnberg P, H&#x000fc;bner CA. First HPSE2 missense mutation in urofacial syndrome. <span><span class="ref-journal">Clin Genet. </span>2012;<span class="ref-vol">81</span>:88–92.</span> [<a href="/pubmed/21332471" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21332471</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.mckenzie.2000.1170">McKenzie E, Tyson K, Stamps A, Smith P, Turner P, Barry R, Hircock M, Patel S, Barry E, Stubberfield C, Terrett J, Page M. Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2000;<span class="ref-vol">276</span>:1170–7.</span> [<a href="/pubmed/11027606" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11027606</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.mermerkaya.2014.661">Mermerkaya M, S&#x000fc;er E, &#x000d6;zt&#x000fc;rk E, G&#x000fc;lp&#x00131;nar &#x000d6;, G&#x000f6;k&#x000e7;e M&#x00130;, Yal&#x000e7;&#x00131;nda&#x0011f; FN, Soyg&#x000fc;r T, Burgu B. Nocturnal lagophthalmos in children with urofacial syndrome (Ochoa): a novel sign. <span><span class="ref-journal">Eur J Pediatr. </span>2014;<span class="ref-vol">173</span>:661–65.</span> [<a href="/pubmed/24248520" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24248520</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.moreno.2018.669">Moreno CA, Sobreira N, Pugh E, Zhang P, Steel G, Torres FR, Cavalcanti DP. Homozygous deletion in MYL9 expands the molecular basis of megacystis&#x02013;microcolon&#x02013;intestinal hypoperistalsis syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2018;<span class="ref-vol">26</span>:669–75.</span> [<a href="/pmc/articles/PMC5945668/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5945668</span></a>] [<a href="/pubmed/29453416" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29453416</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.nicanor.2005.477">Nicanor FA, Cook A, Pippi-Salle JL. Early diagnosis of the urofacial syndrome is essential to prevent irreversible renal failure. <span><span class="ref-journal">Int Braz J Urol. </span>2005;<span class="ref-vol">31</span>:477–81.</span> [<a href="/pubmed/16255797" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16255797</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.nilsson.2001.1155">Nilsson J, Vallbo C, Guo D, Golovleva I, Hallberg B, Henriksson R, Hedman H. Cloning, characterization, and expression of human LIG1. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2001;<span class="ref-vol">284</span>:1155–61.</span> [<a href="/pubmed/11414704" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11414704</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.ochoa.1987.661">Ochoa B, Gorlin RJ. Urofacial (Ochoa) syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1987;<span class="ref-vol">27</span>:661–7.</span> [<a href="/pubmed/3631137" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3631137</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.ochoa.2004.6">Ochoa B. Can a congenital dysfunctional bladder be diagnosed from a smile? The Ochoa syndrome updated. <span><span class="ref-journal">Pediatr Nephrol. </span>2004;<span class="ref-vol">19</span>:6–12.</span> [<a href="/pubmed/14648341" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14648341</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.ochoa.1992.580">Ochoa B. The urofacial (Ochoa) syndrome revisited. <span><span class="ref-journal">J Urol. </span>1992;<span class="ref-vol">148</span>:580–3.</span> [<a href="/pubmed/1640526" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1640526</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.pang.2010.957">Pang J, Zhang S, Yang P, Hawkins-Lee B, Zhong J, Zhang Y, Ochoa B, Agundez JA, Voelckel MA, Fisher RB, Gu W, Xiong WC, Mei L, She JX, Wang CY. Loss-of-function mutations in HPSE2 cause the autosomal recessive urofacial syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">86</span>:957–62.</span> [<a href="/pmc/articles/PMC3032074/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3032074</span></a>] [<a href="/pubmed/20560209" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20560209</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.richer.2012.664">Richer J, Milewicz DM, Gow R, de Nanassy J, Maharajh G, Miller E, Oppenheimer L, Weiler G, O'Connor M. R179H mutation in ACTA2 expanding the phenotype to include prune-belly sequence and skin manifestations. <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:664–8.</span> [<a href="/pubmed/22302747" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22302747</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.roberts.2014.4302">Roberts NA, Woolf AS, Stuart HM, Thuret R, McKenzie EA, Newman WG, Hilton EN. Heparanase 2, mutated in urofacial syndrome, mediates peripheral neural development in Xenopus. <span><span class="ref-journal">Hum Mol Genet. </span>2014;<span class="ref-vol">23</span>:4302–14.</span> [<a href="/pmc/articles/PMC4103677/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4103677</span></a>] [<a href="/pubmed/24691552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24691552</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.sk_lov_.2006.125">Sk&#x000e1;lov&#x000e1; S, Rejtar I, Nov&#x000e1;k I, J&#x000fc;ttnerov&#x000e1; V. The urofacial (Ochoa) syndrome--first case in the central European population. <span><span class="ref-journal">Prague Med Rep. </span>2006;<span class="ref-vol">107</span>:125–9.</span> [<a href="/pubmed/16752812" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16752812</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.stamatiou.2010.582">Stamatiou KN, Karakos CD. Urofacial syndrome: A subset of neurogenic bladder dysfunction syndromes? <span><span class="ref-journal">Indian J Urol. </span>2010;<span class="ref-vol">26</span>:582–4.</span> [<a href="/pmc/articles/PMC3034072/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3034072</span></a>] [<a href="/pubmed/21369396" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21369396</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.stuart.2013.259">Stuart HM, Roberts NA, Burgu B, Daly SB, Urquhart JE, Bhaskar S, Dickerson JE, Mermerkaya M, Silay MS, Lewis MA, Olondriz MB, Gener B, Beetz C, Varga RE, G&#x000fc;lp&#x00131;nar O, S&#x000fc;er E, Soyg&#x000fc;r T, Oz&#x000e7;akar ZB, Yal&#x000e7;&#x00131;nkaya F, Kavaz A, Bulum B, G&#x000fc;c&#x000fc;k A, Yue WW, Erdogan F, Berry A, Hanley NA, McKenzie EA, Hilton EN, Woolf AS, Newman WG. LRIG2 mutations cause urofacial syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2013;<span class="ref-vol">92</span>:259–64.</span> [<a href="/pmc/articles/PMC3567269/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3567269</span></a>] [<a href="/pubmed/23313374" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23313374</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.stuart.2015.797">Stuart HM, Roberts NA, Hilton EN, McKenzie EA, Daly SB, Hadfield KD, Rahal JS, Gardiner NJ, Tanley SW, Lewis MA, Sites E, Angle B, Alves C, Louren&#x000e7;o T, Rodrigues M, Calado A, Amado M, Guerreiro N, Serras I, Beetz C, Varga RE, Silay MS, Darlow JM, Dobson MG, Barton DE, Hunziker M, Puri P, Feather SA, Goodship JA, Goodship TH, Lambert HJ, Cordell HJ, Saggar A, Kinali M, Lorenz C, Moeller K, Schaefer F, Bayazit AK, Weber S, Newman WG, Woolf AS, et al.  Urinary tract effects of HPSE2 mutations. <span><span class="ref-journal">J Am Soc Nephrol. </span>2015;<span class="ref-vol">26</span>:797–804.</span> [<a href="/pmc/articles/PMC4378092/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4378092</span></a>] [<a href="/pubmed/25145936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25145936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.sutay.2010.445">Sutay NR, Kulkarni R, Arya MK. Ochoa or Urofacial syndrome. <span><span class="ref-journal">Indian Pediatr. </span>2010;<span class="ref-vol">47</span>:445–6.</span> [<a href="/pubmed/20519791" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20519791</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.teebi.1991.199">Teebi AS, Hassoon MM. Urofacial syndrome associated with hydrocephalus due to aqueductal stenosis. <span><span class="ref-journal">Am J Med Genet. </span>1991;<span class="ref-vol">40</span>:199–200.</span> [<a href="/pubmed/1897575" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1897575</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.vivante.2017.69">Vivante A, Hwang DY, Kohl S, Chen J, Shril S, Schulz J, van der Ven A, Daouk G, Soliman NA, Kumar AS, Senguttuvan P, Kehinde EO, Tasic V, Hildebrandt F. Exome sequencing discerns syndromes in patients from consanguineous families with congenital anomalies of the kidneys and urinary tract. <span><span class="ref-journal">J Am Soc Nephrol. </span>2017;<span class="ref-vol">28</span>:69–75.</span> [<a href="/pmc/articles/PMC5198271/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5198271</span></a>] [<a href="/pubmed/27151922" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27151922</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.weber.2011.668">Weber S, Thiele H, Mir S, Toliat MR, Sozeri B, Reutter H, Draaken M, Ludwig M, Altm&#x000fc;ller J, Frommolt P, Stuart HM, Ranjzad P, Hanley NA, Jennings R, Newman WG, Wilcox DT, Schlingmann K-P, Beetz R, Hoyer PF, Konrad M, Schaefer F, N&#x000fc;rnberg P, Woolf AS. Muscarinic acetylcholine receptor M3 (<em>CHRM3</em>) mutation causes urinary bladder disease and a prune-belly like syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">89</span>:668–74.</span> [<a href="/pmc/articles/PMC3213389/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3213389</span></a>] [<a href="/pubmed/22077972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22077972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.woolf.2014a.353">Woolf AS, Stuart HM, Newman WG. Genetics of human congenital urinary bladder disease. <span><span class="ref-journal">Pediatr Nephrol. </span>2014a;<span class="ref-vol">29</span>:353–60.</span> [<a href="/pubmed/23584850" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23584850</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="urofacial.REF.woolf.2014b.513">Woolf AS, Stuart HM, Roberts NA, McKenzie EA, Hilton EN, Newman WG. Urofacial syndrome: a genetic and congenital disease of aberrant urinary bladder innervation. <span><span class="ref-journal">Pediatr Nephrol. </span>2014b;<span class="ref-vol">29</span>:513–8.</span> [<a href="/pubmed/23832138" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23832138</span></a>]</div></li></ul></div></div><div id="urofacial.Chapter_Notes"><h2 id="_urofacial_Chapter_Notes_">Chapter Notes</h2><div id="urofacial.Author_Notes"><h3>Author Notes</h3><p><a href="http://www.human-development.manchester.ac.uk/staff/BillNewman" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Bill Newman</a> is a clinical geneticist with a research program that includes the identification of the causes of rare inherited disorders and subsequent development of targeted treatments.</p><p><a href="http://www.human-development.manchester.ac.uk/staff/AdrianWoolf/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Adrian S Woolf</a> is a clinician scientist and nephrologist. His research interest is to find out why some children are born with abnormal renal tracts.</p></div><div id="urofacial.Author_History"><h3>Author History</h3><p>William G Newman, MD, PhD (2013-present)<br />Helen M Stuart, MD; University of Manchester and Central Manchester University Hospitals NHS Foundation Trust (2013-2018)<br />Adrian S Woolf, MD (2013-present)</p></div><div id="urofacial.Acknowledgments"><h3>Acknowledgments</h3><p>The authors' work on UFS has been funded by Kidney Research UK, Newlife, the Medical Research Council, and the Wellcome Trust.</p></div><div id="urofacial.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 June 2018 (bp) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 August 2013 (me) Review posted live</div></li><li class="half_rhythm"><div>17 May 2013 (wgn) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK154138</span><span class="label">PMID: <a href="/pubmed/23967498" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">23967498</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ucd-overview/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/usher1/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK154138&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK154138/?report=reader">PubReader</a></li><li><a href="/books/NBK154138/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK154138" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK154138" style="display:none" title="Cite this Page"><div class="bk_tt">Newman WG, Woolf AS. Urofacial Syndrome. 2013 Aug 22 [Updated 2018 Jun 7]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK154138/pdf/Bookshelf_NBK154138.pdf">PDF version of this page</a> (450K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#urofacial.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#urofacial.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#urofacial.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#urofacial.Genetically_Related_Allelic_Di" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#urofacial.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#urofacial.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#urofacial.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#urofacial.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#urofacial.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#urofacial.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#urofacial.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=60495[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HPSE2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9860[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">LRIG2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK154138+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=3049396" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3049396" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3049396" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=3049396" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24966895" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Clinical and genetic characteristics for the Urofacial Syndrome (UFS).</a><span class="source">[Int J Clin Exp Pathol. 2014]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Clinical and genetic characteristics for the Urofacial Syndrome (UFS).<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tu Y, Yang P, Yang J, Xu Y, Xiong F, Yu Q, Gu W, Pond D, Mendelsohn N, Lachmeijer GA, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Int J Clin Exp Pathol. 2014; 7(5):1842-8. Epub 2014 Apr 15.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301444" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alström Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alström Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Paisey RB, Steeds R, Barrett T, Williams D, Geberhiwot T, Gunay-Aygun M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23832138" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Urofacial syndrome: a genetic and congenital disease of aberrant urinary bladder innervation.</a><span class="source">[Pediatr Nephrol. 2014]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Urofacial syndrome: a genetic and congenital disease of aberrant urinary bladder innervation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Woolf AS, Stuart HM, Roberts NA, McKenzie EA, Hilton EN, Newman WG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pediatr Nephrol. 2014 Apr; 29(4):513-8. Epub 2013 Jul 9.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26072522" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ACTG2</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ACTG2</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wangler MF, Beaudet AL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23313374" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">LRIG2 mutations cause urofacial syndrome.</a><span class="source">[Am J Hum Genet. 2013]</span><div class="brieflinkpop offscreen_noflow">LRIG2 mutations cause urofacial syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Stuart HM, Roberts NA, Burgu B, Daly SB, Urquhart JE, Bhaskar S, Dickerson JE, Mermerkaya M, Silay MS, Lewis MA, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Hum Genet. 2013 Feb 7; 92(2):259-64. Epub 2013 Jan 11.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=23967498" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=23967498" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc8e0f75f66d18aa351a7d">Urofacial Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Urofacial Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:02:07-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88701FDFC875E1000000000341015F&amp;ncbi_session=CE88701FDFC8E0F1_0833SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK154138%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK154138&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK154138/&amp;ncbi_pagename=Urofacial Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88701FDFC8E0F1_0833SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>